Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Ark Genomic Revolution ETF (ARKG)

105.25   -5.44 (-4.91%) 01-27 05:19
Open: 110.9 Pre. Close: 110.69
High: 112 Low: 105.0611
Volume: 6,113,579 Market Cap: 0M
ARKG was created on 10/31/14 by ARK. The ETF is an actively managed fund that targets companies involved in the genomics industry.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 111.26 - 111.846 111.846 - 112.345
Low: 103.626 - 104.269 104.269 - 104.816
Close: 104.181 - 105.265 105.265 - 106.188

Technical analysis

as of: 2021-01-26 4:41:08 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 134.12     One year: 156.65
Support: Support1: 99.76    Support2: 90.45
Resistance: Resistance1: 114.83    Resistance2: 134.12
Pivot: 106.06
Moving Average: MA(5): 109.69     MA(20): 103.45
MA(100): 79.93     MA(250): 58.63
MACD: MACD(12,26): 4.62     Signal(9): 4.92
Stochastic oscillator: %K(14,3): 73.87     %D(3): 79.16
RSI: RSI(14): 55.08
52-week: High: 114.83  Low: 24.00  Change(%): 209.1
Average Vol(K): 3-Month: 401993  10-Days: 576479

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ARKG has closed above bottom band by 46.0%. Bollinger Bands are 40.1% wider than normal. The large width of the bands suggest high volatility as compared to ARKG's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue.

Headline News

Tue, 26 Jan 2021
An 'Omics Revolution: What's Next for High-Flying 'ARKG' - ETF Trends

Mon, 25 Jan 2021
Interesting ARKG Put And Call Options For March 19th - Nasdaq

Sun, 24 Jan 2021
3 Stocks ARK Invest's Red-Hot ETFs Bought Last Week - Motley Fool

Thu, 21 Jan 2021
ARKG: Access the Latest and Greatest Genomics Innovation - ETF Trends

Tue, 19 Jan 2021
The ARKG ETF: Join the Genomics Revolution - ETF Trends

Mon, 18 Jan 2021
This ARK ETF Is Off To Another Fast Start In 2021 - TheStreet

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  ETF
Sector: 
Industry: 
Shares Out. (M)
Shares Float (M) 1
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.